Leisure Time Physical Activity of Moderate to Vigorous Intensity and Mortality: A Large Pooled Cohort Analysis
Background:
Leisure time physical activity reduces the risk of premature mortality, but the years of life expectancy gained at different levels remains unclear. Our objective was to determine the years of life gained after age 40 associated with various levels of physical activity, both overall and according to body mass index (BMI) groups, in a large pooled analysis.
Methods and Findings:
We examined the association of leisure time physical activity with mortality during follow-up in pooled data from six prospective cohort studies in the National Cancer Institute Cohort Consortium, comprising 654,827 individuals, 21–90 y of age. Physical activity was categorized by metabolic equivalent hours per week (MET-h/wk). Life expectancies and years of life gained/lost were calculated using direct adjusted survival curves (for participants 40+ years of age), with 95% confidence intervals (CIs) derived by bootstrap. The study includes a median 10 y of follow-up and 82,465 deaths. A physical activity level of 0.1–3.74 MET-h/wk, equivalent to brisk walking for up to 75 min/wk, was associated with a gain of 1.8 (95% CI: 1.6–2.0) y in life expectancy relative to no leisure time activity (0 MET-h/wk). Higher levels of physical activity were associated with greater gains in life expectancy, with a gain of 4.5 (95% CI: 4.3–4.7) y at the highest level (22.5+ MET-h/wk, equivalent to brisk walking for 450+ min/wk). Substantial gains were also observed in each BMI group. In joint analyses, being active (7.5+ MET-h/wk) and normal weight (BMI 18.5–24.9) was associated with a gain of 7.2 (95% CI: 6.5–7.9) y of life compared to being inactive (0 MET-h/wk) and obese (BMI 35.0+). A limitation was that physical activity and BMI were ascertained by self report.
Conclusions:
More leisure time physical activity was associated with longer life expectancy across a range of activity levels and BMI groups.
Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Leisure Time Physical Activity of Moderate to Vigorous Intensity and Mortality: A Large Pooled Cohort Analysis. PLoS Med 9(11): e32767. doi:10.1371/journal.pmed.1001335
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001335
Souhrn
Background:
Leisure time physical activity reduces the risk of premature mortality, but the years of life expectancy gained at different levels remains unclear. Our objective was to determine the years of life gained after age 40 associated with various levels of physical activity, both overall and according to body mass index (BMI) groups, in a large pooled analysis.
Methods and Findings:
We examined the association of leisure time physical activity with mortality during follow-up in pooled data from six prospective cohort studies in the National Cancer Institute Cohort Consortium, comprising 654,827 individuals, 21–90 y of age. Physical activity was categorized by metabolic equivalent hours per week (MET-h/wk). Life expectancies and years of life gained/lost were calculated using direct adjusted survival curves (for participants 40+ years of age), with 95% confidence intervals (CIs) derived by bootstrap. The study includes a median 10 y of follow-up and 82,465 deaths. A physical activity level of 0.1–3.74 MET-h/wk, equivalent to brisk walking for up to 75 min/wk, was associated with a gain of 1.8 (95% CI: 1.6–2.0) y in life expectancy relative to no leisure time activity (0 MET-h/wk). Higher levels of physical activity were associated with greater gains in life expectancy, with a gain of 4.5 (95% CI: 4.3–4.7) y at the highest level (22.5+ MET-h/wk, equivalent to brisk walking for 450+ min/wk). Substantial gains were also observed in each BMI group. In joint analyses, being active (7.5+ MET-h/wk) and normal weight (BMI 18.5–24.9) was associated with a gain of 7.2 (95% CI: 6.5–7.9) y of life compared to being inactive (0 MET-h/wk) and obese (BMI 35.0+). A limitation was that physical activity and BMI were ascertained by self report.
Conclusions:
More leisure time physical activity was associated with longer life expectancy across a range of activity levels and BMI groups.
Please see later in the article for the Editors' Summary
Zdroje
1. BrownsonRC, BoehmerTK, LukeDA (2005) Declining rates of physical activity in the United States: what are the contributors? Annu Rev Public Health 26: 421–443.
2. KatzmarzykPT, MasonC (2009) The physical activity transition. J Phys Act Health 6: 269–280.
3. OlshanskySJ, PassaroDJ, HershowRC, LaydenJ, CarnesBA, et al. (2005) A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 352: 1138–1145.
4. Crimmins EM, Preston SH, Cohen B, Panel on Understanding Divergent Trends in Longevity in High-Income Countries (2011) Report of the National Research Council of the National Academies. Explaining divergent levels of longevity in high-income countries. Washington (District of Columbia): The National Academies Press.
5. LeeIM, ShiromaEJ, LobeloF, PuskaP, BlairSN, et al. (2012) Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 380: 219–229.
6. Physical Activity Guidelines Advisory Committee (2008) Physical Activity Guidelines Advisory Committee report, 2008. Washington (District of Columbia): US Department of Health and Human Services.
7. PaffenbargerRSJr, HydeRT, WingAL, HsiehCC (1986) Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med 314: 605–613.
8. FrancoOH, DeLC, PeetersA, JonkerJ, MackenbachJ, et al. (2005) Effects of physical activity on life expectancy with cardiovascular disease. Arch Intern Med 165: 2355–2360.
9. WenCP, WaiJP, TsaiMK, YangYC, ChengTY, et al. (2011) Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet 378: 1244–1253.
10. BybergL, MelhusH, GedeborgR, SundstromJ, AhlbomA, et al. (2009) Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. BMJ 338: b688.
11. FraserGE, ShavlikDJ (2001) Ten years of life: Is it a matter of choice? Arch Intern Med 161: 1645–1652.
12. FogelholmM (2010) Physical activity, fitness and fatness: relations to mortality, morbidity and disease risk factors. A systematic review. Obes Rev 11: 202–221.
13. Berrington deGA, HartgeP, CerhanJR, FlintAJ, HannanL, et al. (2010) Body-mass index and mortality among 1.46 million white adults. N Engl J Med 363: 2211–2219.
14. National Cancer Institute (2010) Cohort Consortium. Available: http://epi.grants.cancer.gov/Consortia/cohort.html. Accessed 10 September 2012.
15. KosterA, HarrisTB, MooreSC, SchatzkinA, HollenbeckAR, et al. (2009) Joint associations of adiposity and physical activity with mortality: the National Institutes of Health-AARP Diet and Health Study. Am J Epidemiol 169: 1344–1351.
16. CalleEE, RodriguezC, JacobsEJ, AlmonML, ChaoA, et al. (2002) The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer 94: 2490–2501.
17. GenkingerJM, PlatzEA, HoffmanSC, ComstockGW, HelzlsouerKJ (2004) Fruit, vegetable, and antioxidant intake and all-cause, cancer, and cardiovascular disease mortality in a community-dwelling population in Washington County, Maryland. Am J Epidemiol 160: 1223–1233.
18. HowardRA, LeitzmannMF, LinetMS, FreedmanDM (2009) Physical activity and breast cancer risk among pre- and postmenopausal women in the U.S. Radiologic Technologists cohort. Cancer Causes Control 20: 323–333.
19. LeeIM, CookNR, GazianoJM, GordonD, RidkerPM, et al. (2005) Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 294: 56–65.
20. CookNR, LeeIM, GazianoJM, GordonD, RidkerPM, et al. (2005) Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 294: 47–55.
21. RidkerPM, CookNR, LeeIM, GordonD, GazianoJM, et al. (2005) A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 352: 1293–1304.
22. MargolisKL, MucciL, BraatenT, KumleM, TrolleLY, et al. (2005) Physical activity in different periods of life and the risk of breast cancer: the Norwegian-Swedish Women's Lifestyle and Health cohort study. Cancer Epidemiol Biomarkers Prev 14: 27–32.
23. US Department of Health and Human Services (2008) 2008 physical activity guidelines for Americans. Washington (District of Columbia): US Department of Health and Human Services.
24. AinsworthBE, HaskellWL, WhittMC, IrwinML, SwartzAM, et al. (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32: S498–S504.
25. Lee I-M, Paffenbarger RS Jr (2009) Design of present-day epidemiologic studies of physical activity and health. In: Lee I-M, Blair SN, Manson JE, Paffenbarger RS Jr, editors. Epidemiologic methods in physical activity studies. New York: Oxford University Press. pp. 100–123.
26. SchuitAJ, SchoutenEG, WesterterpKR, SarisWH (1997) Validity of the Physical Activity Scale for the Elderly (PASE): according to energy expenditure assessed by the doubly labeled water method. J Clin Epidemiol 50: 541–546.
27. World Health Organization (2010) Global recommendations on physical activity for health. Geneva: World Health Organization.
28. DurrlemanS, SimonR (1989) Flexible regression models with cubic splines. Stat Med 8: 551–561.
29. DerSimonianR, LairdN (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177–188.
30. HigginsJP, ThompsonSG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539–1558.
31. GhaliWA, QuanH, BrantR, van MelleG, NorrisCM, et al. (2001) Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. JAMA 286: 1494–1497.
32. MakuchRW (1982) Adjusted survival curve estimation using covariates. J Chronic Dis 35: 437–443.
33. Efron B, Tibshirani RJ (1993) An introduction to the bootstrap. New York: Chapman & Hall.
34. World Health Organization (1995) Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 854: 1–452.
35. DollR, PetoR, BorehamJ, SutherlandI (2004) Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 328: 1519.
36. LeeCD, BlairSN, JacksonAS (1999) Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. Am J Clin Nutr 69: 373–380.
37. FerrariP, FriedenreichC, MatthewsCE (2007) The role of measurement error in estimating levels of physical activity. Am J Epidemiol 166: 832–840.
38. SpiegelmanD, SchneeweissS, McDermottA (1997) Measurement error correction for logistic regression models with an “alloyed gold standard”. Am J Epidemiol 145: 184–196.
39. MatthewsCE, MooreSC, GeorgeSM, SampsonJ, BowlesHR (2012) Improving self-reports of active and sedentary behaviors in large epidemiologic studies. Exerc Sport Sci Rev 40: 118–126.
40. MahabirS, BaerDJ, GiffenC, ClevidenceBA, CampbellWS, et al. (2006) Comparison of energy expenditure estimates from 4 physical activity questionnaires with doubly labeled water estimates in postmenopausal women. Am J Clin Nutr 84: 230–236.
41. MatthewsCE, JurjAL, ShuXO, LiHL, YangG, et al. (2007) Influence of exercise, walking, cycling, and overall nonexercise physical activity on mortality in Chinese women. Am J Epidemiol 165: 1343–1350.
42. MatthewsCE, GeorgeSM, MooreSC, BowlesHR, BlairA, et al. (2012) Amount of time spent in sedentary behaviors and cause-specific mortality in US adults. Am J Clin Nutr 95: 437–445.
43. ShieldsM, GorberSC, TremblayMS (2008) Effects of measurement on obesity and morbidity. Health Rep 19: 77–84.
44. SunQ, van DamRM, SpiegelmanD, HeymsfieldSB, WillettWC, et al. (2010) Comparison of dual-energy x-ray absorptiometric and anthropometric measures of adiposity in relation to adiposity-related biologic factors. Am J Epidemiol 172: 1442–1454.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2012 Číslo 11
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based Map
- Screening for Chronic Kidney Disease: Preventing Harm or Harming the Healthy?
- The Long-Term Health Consequences of Child Physical Abuse, Emotional Abuse, and Neglect: A Systematic Review and Meta-Analysis
- Screening and Rapid Molecular Diagnosis of Tuberculosis in Prisons in Russia and Eastern Europe: A Cost-Effectiveness Analysis